Patent · US Active

Compositions comprising synthetic polynucleotides encoding CRISPR related proteins and synthetic sgRNAs and methods of use

US11027025B2 · kind B2 · utility

32Cited by
49References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 11, 2014
Grant dateJun 8, 2021
Priority date
Expiry dateJul 11, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/346
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compositions comprising and methods of using synthetic polynucleotides, e.g., modified mRNA, encoding CRISPR related proteins including dCAS9 and synthetic sgRNAs targeting a gene of interest.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.